Metronidazole Noridem

Metronidazole, the active ingredient in Metronidazole Noridem, is a nitroimidazole presented as an injection for intravenous use. It treats anaerobic bacterial infections and certain protozoal infections in adults and children as prescribed.

GNH USA supplies Metronidazole Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Metronidazole Noridem is a nitroimidazole antimicrobial used to treat infections caused by anaerobic bacteria and susceptible protozoa.

- Bacterial vaginosis: eradicates the anaerobic bacteria responsible, relieving discharge and odor. - Trichomoniasis: eliminates Trichomonas vaginalis, curing infection and preventing recurrence. - Amebic dysentery: destroys Entamoeba histolytica trophozoites, reducing intestinal inflammation. - Giardiasis: clears Giardia lamblia, alleviating diarrhea and malabsorption. - Anaerobic bacterial infections: targets a broad range of anaerobes in intra‑abdominal, skin and soft‑tissue infections. - Clostridioides difficile infection: suppresses toxin‑producing C. difficile, aiding clinical resolution.

Metronidazole Noridem may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Headache: occasional mild to moderate headache. - Diarrhea: loose stools during therapy.

Serious or Rare Side Effects: - Seizures: rare neurologic events requiring immediate attention. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Hepatic toxicity: elevated liver enzymes or jaundice. - Stevens‑Johnson syndrome: severe skin blistering. - Neutropenia: marked reduction in white blood cells.

Before using Metronidazole Noridem, consider the following safety measures. - Renal impairment: adjust dosing and monitor renal function. - Hepatic impairment: use with caution and monitor liver enzymes. - Alcohol consumption: avoid alcohol to prevent a disulfiram‑like reaction. - Pregnancy: prescribe only if the potential benefit outweighs the risk. - Concurrent metronidazole therapy: avoid duplicate therapy to prevent excess exposure. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Metronidazole Noridem can interact with several medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Alcohol: may cause severe nausea, vomiting, and flushing. - Warfarin: can increase anticoagulant effect and bleeding risk. - Lithium: may raise lithium concentrations, leading to toxicity.

Moderate Interactions (Monitor Closely): - Cimetidine: may raise metronidazole plasma levels. - Phenobarbital: may reduce metronidazole concentrations, lowering efficacy. - Oral contraceptives: may decrease hormonal effectiveness, requiring additional contraception.